These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38247182)

  • 1. Myocardial perfusion in cardiac amyloidosis.
    Chacko L; Kotecha T; Ioannou A; Patel N; Martinez-Naharro A; Razvi Y; Patel R; Massa P; Venneri L; Brown J; Porcari A; Knott K; Manisty C; Knight D; Lockie T; Rakhit R; Lachmann H; Wechelakar A; Whelan C; Ponticos M; Moon J; González A; Gilbertson J; Riefolo M; Leone O; Xue H; Hawkins P; Kellman P; Gillmore J; Fontana M
    Eur J Heart Fail; 2024 Mar; 26(3):598-609. PubMed ID: 38247182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance.
    Li R; Yang ZG; Wen LY; Liu X; Xu HY; Zhang Q; Guo YK
    J Cardiovasc Magn Reson; 2016 Apr; 18():16. PubMed ID: 27048459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.
    Knight DS; Zumbo G; Barcella W; Steeden JA; Muthurangu V; Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Kotecha T; Francis R; Rezk T; Quarta CC; Whelan CJ; Lachmann HJ; Wechalekar AD; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):823-833. PubMed ID: 29680336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.
    Chatzantonis G; Bietenbeck M; Florian A; Meier C; Stalling P; Korthals D; Reinecke H; Yilmaz A
    Clin Res Cardiol; 2021 Jan; 110(1):136-145. PubMed ID: 32372287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion Tensor Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
    Khalique Z; Ferreira PF; Scott AD; Nielles-Vallespin S; Martinez-Naharro A; Fontana M; Hawkins P; Firmin DN; Pennell DJ
    Circ Cardiovasc Imaging; 2020 May; 13(5):e009901. PubMed ID: 32408830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal Coronary Flow Velocity Reserve and Decreased Myocardial Contractile Reserve Are Main Factors in Relation to Physical Exercise Capacity in Cardiac Amyloidosis.
    Clemmensen TS; Eiskjær H; Mølgaard H; Larsen AH; Soerensen J; Andersen NF; Tolbod LP; Harms HJ; Poulsen SH
    J Am Soc Echocardiogr; 2018 Jan; 31(1):71-78. PubMed ID: 29111120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy.
    Camaioni C; Knott KD; Augusto JB; Seraphim A; Rosmini S; Ricci F; Boubertakh R; Xue H; Hughes R; Captur G; Lopes LR; Brown LAE; Manisty C; Petersen SE; Plein S; Kellman P; Mohiddin SA; Moon JC
    Heart; 2020 Jun; 106(11):824-829. PubMed ID: 31822572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.
    Hashimura H; Ishibashi-Ueda H; Yonemoto Y; Ohta-Ogo K; Matsuyama TA; Ikeda Y; Morita Y; Yamada N; Yasui H; Naito H
    Heart Vessels; 2016 Jun; 31(6):990-5. PubMed ID: 25794983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated Pixel-Wise Quantitative Myocardial Perfusion Mapping by CMR to Detect Obstructive Coronary Artery Disease and Coronary Microvascular Dysfunction: Validation Against Invasive Coronary Physiology.
    Kotecha T; Martinez-Naharro A; Boldrini M; Knight D; Hawkins P; Kalra S; Patel D; Coghlan G; Moon J; Plein S; Lockie T; Rakhit R; Patel N; Xue H; Kellman P; Fontana M
    JACC Cardiovasc Imaging; 2019 Oct; 12(10):1958-1969. PubMed ID: 30772231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of myocardial ischemia and infarction assessed by dynamic computed tomography perfusion imaging and comparison with cardiac magnetic resonance and single-photon emission computed tomography.
    Tanabe Y; Kido T; Uetani T; Kurata A; Kono T; Ogimoto A; Miyagawa M; Soma T; Murase K; Iwaki H; Mochizuki T
    Eur Radiol; 2016 Nov; 26(11):3790-3801. PubMed ID: 26852220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of global myocardial perfusion reserve assessment based on coronary sinus flow measurements using cardiovascular magnetic resonance in addition to myocardial stress perfusion imaging.
    Shomanova Z; Florian A; Bietenbeck M; Waltenberger J; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2017 May; 18(8):851-859. PubMed ID: 28369259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative three-dimensional cardiovascular magnetic resonance myocardial perfusion imaging in systole and diastole.
    Motwani M; Kidambi A; Sourbron S; Fairbairn TA; Uddin A; Kozerke S; Greenwood JP; Plein S
    J Cardiovasc Magn Reson; 2014 Feb; 16(1):19. PubMed ID: 24565078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis.
    Dorbala S; Vangala D; Bruyere J; Quarta C; Kruger J; Padera R; Foster C; Hanley M; Di Carli MF; Falk R
    JACC Heart Fail; 2014 Aug; 2(4):358-67. PubMed ID: 25023822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive Mapping of the Electrophysiological Substrate in Cardiac Amyloidosis and Its Relationship to Structural Abnormalities.
    Orini M; Graham AJ; Martinez-Naharro A; Andrews CM; de Marvao A; Statton B; Cook SA; O'Regan DP; Hawkins PN; Rudy Y; Fontana M; Lambiase PD
    J Am Heart Assoc; 2019 Sep; 8(18):e012097. PubMed ID: 31496332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
    Cuddy SAM; Bravo PE; Falk RH; El-Sady S; Kijewski MF; Park MA; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Cheng SC; Jerosch-Herold M; Kwong RY; Liao R; Dorbala S
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1325-1336. PubMed ID: 32417333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial function and geometry differences in transthyretin versus immunoglobulin light chain amyloidosis: a cardiac magnetic resonance study.
    Palmer C; Truong VT; Slivnick JA; Wolking S; Coleman P; Mazur W; Zareba KM
    Sci Rep; 2022 Jan; 12(1):140. PubMed ID: 34996915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced global myocardial perfusion reserve in DCM and HCM patients assessed by CMR-based velocity-encoded coronary sinus flow measurements and first-pass perfusion imaging.
    Bietenbeck M; Florian A; Shomanova Z; Meier C; Yilmaz A
    Clin Res Cardiol; 2018 Nov; 107(11):1062-1070. PubMed ID: 29774406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
    Fontana M; Ćorović A; Scully P; Moon JC
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
    Baggiano A; Boldrini M; Martinez-Naharro A; Kotecha T; Petrie A; Rezk T; Gritti M; Quarta C; Knight DS; Wechalekar AD; Lachmann HJ; Perlini S; Pontone G; Moon JC; Kellman P; Gillmore JD; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):69-80. PubMed ID: 31202744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac amyloidosis is not a single disease: a multiparametric comparison between the light chain and transthyretin forms.
    Neculae G; Adam R; Jercan A; Bădeliță S; Tjahjadi C; Draghici M; Stan C; Bax JJ; Popescu BA; Marsan NA; Coriu D; Jurcuț R
    ESC Heart Fail; 2024 Oct; 11(5):2825-2834. PubMed ID: 38757395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.